Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

The University of Delaware’s long-running Clinical Trials Management Certificate program, now in its 16th year, is open for spring registration. The next 14-week online course starts Feb. 10. Offered ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

The past decade has seen many innovations in clinical trials, including new trial formats 1, novel endpoints 2, new biomarkers and ways of stratifying patients 3, a broader set of data sources such as ...

AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should always be implemented with the end goal in mind—helping patients.

The high cost and complexity of drug discovery and development make clinical trial outcomes critical for regulatory approval and patient care. However, limited availability of large-scale, ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

Why is tokenization important for the future of medicine development? A tremendous amount of data is collected throughout a clinical trial, but prior to tokenization, the life science industry did not ...

The deal is designed to combine patient voices and objective outcome measures to build compelling regulatory cases without requiring sponsors to navigate multiple vendors, data sets and integration ...